BI-0474 manufacturers
- BI-0474
-
- $52.00 / 1mg
-
2026-04-22
- CAS:2750570-55-7
- Min. Order:
- Purity: 99.96%
- Supply Ability: 10g
- BI-0474
-
- $0.00 / 10mg
-
2025-03-16
- CAS:2750570-55-7
- Min. Order: 5mg
- Purity: 98%+ HPLC HNMR
- Supply Ability: 10g
|
| | BI-0474 Basic information |
| Product Name: | BI-0474 | | Synonyms: | Benzo[b]thiophene-3-carbonitrile, 2-amino-4-[3-[6-[(2S)-2,4-dimethyl-1-piperazinyl]-4-[4-(1-oxo-2-propen-1-yl)-1-piperazinyl]-2-pyridinyl]-1,2,4-oxadiazol-5-yl]-4,5,6,7-tetrahydro-4-methyl-, (4S)-;BI-0474 | | CAS: | 2750570-55-7 | | MF: | C30H37N9O2S | | MW: | 587.74 | | EINECS: | | | Product Categories: | | | Mol File: | 2750570-55-7.mol |  |
| | BI-0474 Chemical Properties |
| Boiling point | 879.4±75.0 °C(Predicted) | | density | 1.38±0.1 g/cm3(Predicted) | | form | Solid | | pka | 7.13±0.70(Predicted) | | color | White to off-white | | InChIKey | CKAMBYUZKWQCKJ-ADSBAMQRSA-N | | SMILES | C12CCC[C@@](C3ON=C(C4=NC(N5CCN(C)C[C@@H]5C)=CC(N5CCN(C(=O)C=C)CC5)=C4)N=3)(C)C=1C(C#N)=C(N)S2 |
| | BI-0474 Usage And Synthesis |
| Description | BI-0474 is a potent KRASG12C inhibitor with an IC50 value of 7.0 nM. | | Uses |
BI-0474 is a potent KRASG12C inhibitor with an IC50 value of 7.0 nM for the GDP-KRAS::SOS1 protein-protein interaction. It exhibits good anti-proliferative activity against NCI-H358 cells carrying the G12C mutation. BI-0474 also shows good anti-tumour activity in non-small cell lung cancer xenograft models.
| | in vitro | BI-0474 (1-10,000 nM; 3 days) shows potent antiproliferative activity of 26 nM on NCI-H358 cells carrying a G12C mutation.
| | in vivo | BI-0474 (40 mg/kg; i.p.; single daily for 3 days) shows anti-tumor efficacy and pharmacodynamic biomarker modulation in an NCI-H358 cell line-derived non-small cell lung cancer xenograft model
| | IC 50 | KRAS-SOS1: 7.0 nM (IC50) |
| | BI-0474 Preparation Products And Raw materials |
|